DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per share of common stock. The dividend is payable on Jan. 2, 2020, to shareholders of record as of Dec. 6, 2019. The indicated annual dividend rate is $0.88 per share of common stock.
About Baxter
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.
More on illi News
This release includes forward-looking statements concerning Baxter's dividends and rates thereof. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: continued strength in the company's financial position, including cash flows; alternative uses of funds including, but not limited to dividends, share repurchases, research and development, business development transactions and other investments in the company's businesses; developments in the previously announced investigation related to foreign exchange gains and losses; and other risks identified in the company's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.
Baxter is a registered trademark of Baxter International Inc.
About Baxter
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.
More on illi News
- Bootstrapped SaaS startup JustCall ranks 54th Fastest Growing Company on Deloitte's APAC Technology Fast 500
- Successful Pageant Queen Turned Author & Ex Dash Doll Opens Up About Her Painful Past
- Krueck + Sexton Founding Partner Mark Sexton Elected to IIT Board of Trustees
- InFlight Labs Develops FIRST "GADSS" Aircraft-wide Remote Control for ELT, SATCOM, and ADS-B Distress Tracking Systems
- Toby Eng Recognized as Top National Wealth Management Advisor by Northwestern Mutual
This release includes forward-looking statements concerning Baxter's dividends and rates thereof. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: continued strength in the company's financial position, including cash flows; alternative uses of funds including, but not limited to dividends, share repurchases, research and development, business development transactions and other investments in the company's businesses; developments in the previously announced investigation related to foreign exchange gains and losses; and other risks identified in the company's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.
Baxter is a registered trademark of Baxter International Inc.
Filed Under: Business
0 Comments
Latest on illi News
- 3x Award-winning Book "Love Loss Light" Speaks to Those in Grief
- CDI Global Welcomes Saxenhammer & Co. as a New Member Firm in Germany
- Northwestern Mutual-Chicago Advisor Timothy Ninowski Receives CFP® Certification
- McCorkle Litigation Services, Inc., Chicago to remain independent
- John Gilbert of Rudin Management to Keynote at Connected Real Estate Summit
- Sage IT celebrates milestone with Forbes Technology Council
- Is "Trump and His Magic Wand" really worth 150 Million?
- Reservations Now Open for Chicago Restaurant Week 2020
- 626 acquires the leading injector service solution provider in the Healthcare Technology Management space
- Major International Indoor Soccer League Announces New Indoor Pro League Debut 2020
- Evolve IP Completes Flex Certification for WebEx Calling and Meetings Solutions
- Trans Actor Jesse Todd Tapped for Lead Role in Upcoming Film "Pink Moon"
- R.J. O'Brien Wins 2019 FOW International Award for Non-Bank FCM of the Year, Taking Category for Fourth Consecutive Year
- Zbones Discovers Additional Eardrums In Humans!
- Aldo Dinelli, Houston's Top Celebrity Jeweler - Talks Diamonds
- The Lashe® Announces New Professional Pricing for Lash Aftercare Products
- CDI Global raises capital for Australian Pharmacy Software Giant
- Mayor Lightfoot Announces Gia Biagi to Serve as Commissioner for the Chicago Department of Transportation
- Santia Deck Makes History; Signs Record Breaking Deal With Highly-Anticipated WFLA
- Dbvisit Announces Release of Dbvisit Standby Snapshot